Blood Cell Count Indexes of Systemic Inflammation in Carotid Artery Disease: Current Evidence and Future Perspectives

Paola Dettori1, Panagiotis Paliogiannis2, Rosa M Pascale2

  • 1Center for Cure and Health, Sassari, Italy.

Insights

Blood cell count indexes, like neutrophil-to-lymphocyte ratio (NLR), may predict carotid artery disease and stroke risk. These inflammation markers offer insights into atherosclerotic processes and patient prognosis.

Area of Science:

  • Vascular Medicine
  • Hematology
  • Inflammation Research

Background:

  • Carotid artery disease (CAD) is a significant cause of ischemic stroke, accounting for about 30% of cases.
  • Systemic inflammation plays a crucial role in the pathophysiology of atherosclerosis, the underlying mechanism of CAD.
  • Biomarkers are needed for predicting CAD onset, progression, cerebrovascular events, and patient outcomes.

Purpose of the Study:

  • To review the evidence on the utility of common blood cell count (BCC) indexes in carotid artery disease.
  • To explore the role of BCC indexes in the diagnosis and risk stratification of patients with CAD.
  • To discuss the potential clinical applications of these inflammatory markers in managing CAD.

Main Methods:

  • Systematic review of existing literature on blood cell count indexes and carotid artery disease.
  • Focus on specific BCC indexes: neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), platelet distribution width (PDW), and red cell distribution width (RDW).
  • Analysis of studies investigating the association of these indexes with CAD diagnosis, progression, and cerebrovascular complications.

Main Results:

  • Several BCC indexes, including NLR, MLR, PLR, MPV, PDW, and RDW, have shown associations with systemic inflammation.
  • Evidence suggests these indexes may serve as predictors for the presence and severity of carotid artery stenosis.
  • These markers have also been linked to an increased risk of cerebrovascular events in patients with CAD.

Conclusions:

  • Commonly available BCC indexes represent accessible and potentially valuable tools for assessing systemic inflammation in CAD.
  • These markers may aid in risk stratification and clinical decision-making for patients with carotid artery disease.
  • Further research is warranted to establish definitive clinical guidelines for the use of BCC indexes in CAD management.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
355
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
676
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
200
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
173
Inflammation01:38

Inflammation

Overview
57.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
578